Found: 28
Select item for more details and to access through your institution.
Clinical, neuroimaging, and behavioural risk factors for neurocognitive impairment in Chinese patients with haemophilia: A multicentre study.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 1074, doi. 10.1111/hae.14816
- By:
- Publication type:
- Article
Matching‐adjusted indirect comparison of bleeding outcomes in severe haemophilia A: Comparing valoctocogene roxaparvovec gene therapy, emicizumab prophylaxis, and FVIII replacement prophylaxis.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 1087, doi. 10.1111/hae.14818
- By:
- Publication type:
- Article
Von Willebrand Disease: Gaining a global perspective.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 1104, doi. 10.1111/hae.14804
- By:
- Publication type:
- Article
Development of inhibitors in women with mild haemophilia A and concurrent treatment with immune tolerance therapy and emicizumab.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 1167, doi. 10.1111/hae.14821
- By:
- Publication type:
- Article
Real‐world data for the use of emicizumab in haemophilia A patients with inhibitors – First nationwide report from Korea.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 1163, doi. 10.1111/hae.14819
- By:
- Publication type:
- Article
Design, development and usability of an educational AI chatbot for People with Haemophilia in Senegal.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 1063, doi. 10.1111/hae.14815
- By:
- Publication type:
- Article
Mild FVII deficiency – Correlation between genotype and phenotype.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 1160, doi. 10.1111/hae.14817
- By:
- Publication type:
- Article
Safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose of marstacimab in Chinese participants with severe haemophilia.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 1155, doi. 10.1111/hae.14814
- By:
- Publication type:
- Article
Longitudinal observations of TFPI levels in paediatric Haemophilia A patients.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 1142, doi. 10.1111/hae.14813
- By:
- Publication type:
- Article
Haemophilia joint health score (HJHS) usage, patterns and outcome data in patients with haemophilia A and haemophilia B in Australia: A descriptive study using the Australian Bleeding Disorders Registry (ABDR).
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 1135, doi. 10.1111/hae.14812
- By:
- Publication type:
- Article
HRQoL and psychosocial aspects of burden on caregivers to children with moderate or severe von Willebrand disease.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 1056, doi. 10.1111/hae.14811
- By:
- Publication type:
- Article
Reported prevalence of von Willebrand disease worldwide in relation to income classification.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 975, doi. 10.1111/hae.14810
- By:
- Publication type:
- Article
Emicizumab for acquired haemophilia A: A case series.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 1049, doi. 10.1111/hae.14809
- By:
- Publication type:
- Article
No immunological changes after factor VIII product switch: An in depth analysis in haemophilia A patients.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 1039, doi. 10.1111/hae.14808
- By:
- Publication type:
- Article
Towards achieving a haemophilia‐free mind.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 951, doi. 10.1111/hae.14807
- By:
- Publication type:
- Article
Impact of timing of prophylaxis commencement, F8 genotype and age on factor consumption and health‐related quality of life in patients with severe haemophilia A.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 1032, doi. 10.1111/hae.14806
- By:
- Publication type:
- Article
Acceptability of prenatal diagnosis and prenatal treatment of haemophilia using cell and gene therapies within US haemophilia community.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 1024, doi. 10.1111/hae.14805
- By:
- Publication type:
- Article
Bleeding events in people with congenital haemophilia A without factor VIII inhibitors receiving prophylactic factor VIII treatment: A systematic literature review.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 954, doi. 10.1111/hae.14803
- By:
- Publication type:
- Article
A focus on dominant negative variants in a series of 170 heterozygous FXI‐deficient patients.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 1113, doi. 10.1111/hae.14802
- By:
- Publication type:
- Article
Desmopressin (DDAVP) use in patients with von Willebrand disease: A single‐centre retrospective review of test response and clinical outcomes.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 1095, doi. 10.1111/hae.14801
- By:
- Publication type:
- Article
Clotting factor activity levels and bleeding risk in people with haemophilia playing sports.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 1013, doi. 10.1111/hae.14800
- By:
- Publication type:
- Article
Tandem and inverted duplications in haemophilia A: Breakpoint characterisation provides insight into possible rearrangement mechanisms.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 1121, doi. 10.1111/hae.14799
- By:
- Publication type:
- Article
Clinical features and laboratory diagnostic issues of non‐immune, non‐amyloid related acquired factor X deficiency.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 1150, doi. 10.1111/hae.14798
- By:
- Publication type:
- Article
Real‐world evidence on efmoroctocog alfa in patients with haemophilia A: A systematic literature review of treatment experience in Europe.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 963, doi. 10.1111/hae.14797
- By:
- Publication type:
- Article
Long‐term immunogenicity, efficacy and tolerability of simoctocog alfa in patients with severe haemophilia A who had completed the NuProtect study in previously untreated patients.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 1005, doi. 10.1111/hae.14796
- By:
- Publication type:
- Article
No difference in quality of life between persons with severe haemophilia A and B.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 987, doi. 10.1111/hae.14759
- By:
- Publication type:
- Article
Efficacy and safety of the B‐domain‐deleted TQG202 for on‐demand treatment in moderate and severe haemophilia A patients: A multicentre, single‐arm trial.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 997, doi. 10.1111/hae.14777
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 947, doi. 10.1111/hae.14599
- Publication type:
- Article